Lin Su

904 citations
33 papers · 643 indexed · h-index 14
Topics
Immune cells in cancer (6 papers)Cancer Genomics and Diagnostics (3 papers)Epigenetics and DNA Methylation (3 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Lin Su

30 papers receiving 624 citations

Peers

Lin Su
Comparison fields: 5 of 87
  • Molecular Biology 370
  • Cancer Research 102
  • Health, Toxicology and Mutagenesis 95
  • Environmental Chemistry 94
  • Oncology 69
Replace Pengli Bu with:
Pengli Bu United States
Mathurin Baquié Switzerland
Seyed Mohamad Sadegh Modaresi United States
Andrew D. Burdick United States
Linda A. Warnke United States
Kelie Chen China
Meriem Koual France
Yana Chervona United States
Guangbo Fu China
Nicole V. Soucy United States
Lin Su relative to Pengli Bu United States Pengli Bu's profile →
Citations per field
00.5×6.3×
Pengli Bu · 1×
Citations per year

Countries citing papers authored by Lin Su

Since Specialization
Citations

This map shows the geographic impact of Lin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Su more than expected).

Fields of papers citing papers by Lin Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Su. The network helps show where Lin Su may publish in the future.

Co-authorship network of co-authors of Lin Su

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Su. A scholar is included among the top collaborators of Lin Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Su. Lin Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 0
5 11
6 5
7 2
8 2
9 8
10 23
11 22
12 1
13 2
14 26
15 11
16 124
17 53
18
Arsenic toxicity is enzyme specific and arsenic inhibition of DNA repair is not caused by direct inhibition of repair enzymes
1
19 33
20 25

About Lin Su

Lin Su is a scholar working on Cancer Research, Biotechnology and Immunology, having authored 33 papers that have together received 643 indexed citations. Recurring topics across this work include Immune cells in cancer (6 papers), Cancer Genomics and Diagnostics (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Environmental Chemistry (94 citations), Health, Toxicology and Mutagenesis (95 citations) and Cancer Research (102 citations). Lin Su has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Elizabeth T. Snow, Yu Hu, Catherine B. Klein, Benoit St‐Pierre, Martha Hughes, Sean E. Egan, Ian C. Scott, John‏ Kingdom, James C. Cross and Joanna Leszczyńska. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026